UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 5.

Kemp, D E; Ganocy, S J; Brecher, M; Carlson, B X; Edwards, S; Eudicone, J M; Evoniuk, G; Jansen, W; Leon, A C; Minkwitz, M; Pikalov, A; Stassen, H H; Szegedi, A; Tohen, M; Van Willigenburg, A P P; Calabrese, J R (2011). Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. Journal of Affective Disorders, 130(1-2):171-179.

Stassen, H; Anghelescu, I G; Angst, J; Böker, H; Lötscher, K; Rujescu, D; Szegedi, A; Scharfetter, C (2011). Predicting response to psychopharmacological treatment: survey of recent results. Pharmacopsychiatry, 44(6):263-272.

Szegedi, A; Jansen, W T; Van Willigenburg, A P; Van der Meulen, E; Stassen, H H; Thase, M E (2009). Early improvement as a predictor of treatment outcome in patients with major depressive disorder: Why the first 2 weeks really matter —evidence from 6562 patients. Journal of Clinical Psychiatry, 70(3):344-353.

Szegedi, A; Jansen, W T; Van Willigenburg, A P P; Van der Meulen, E; Stassen, H H; Thase, M E (2009). Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry, 70(3):344-353.

Tadic, A; Rujescu, Dan; Müller, M J; Kohnen, R; Stassen, H H; Szegedi, A; Dahmen, N (2008). Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression. Neuropsychiatric Disease and Treatment, 4(1):269-276.

This list was generated on Sat Jul 22 21:55:11 2017 CEST.